Last reviewed · How we verify
Azatidine (AZATADINE)
Azatidine, also known as azatadine, is a small molecule drug that targets the histamine H1 receptor. It was originally developed and is currently owned by a pharmaceutical company. Azatidine was FDA approved in 1977 for various allergic conditions, including allergic conjunctivitis, rhinitis, and anaphylaxis. The drug is off-patent, meaning it is no longer protected by patents, and there are no generic manufacturers. As an off-patent medication, its commercial status is uncertain.
At a glance
| Generic name | AZATADINE |
|---|---|
| Drug class | azatadine |
| Target | Histamine H1 receptor |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
| First approval | 1977 |
Approved indications
- Allergic conjunctivitis
- Allergic rhinitis
- Anaphylaxis Adjunct
- Common cold
- Dermatographic urticaria
- Itching of skin
- Nasal congestion
- Nasal discharge
- Seasonal allergic rhinitis
- Sneezing
- Urticaria
- Vasomotor rhinitis
Common side effects
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |